Cargando…
Developments in Mannose‐Based Treatments for Uropathogenic Escherichia coli‐Induced Urinary Tract Infections
During their lifetime almost half of women will experience a symptomatic urinary tract infection (UTI) with a further half experiencing a relapse within six months. Currently UTIs are treated with antibiotics, but increasing antibiotic resistance rates highlight the need for new treatments. Uropatho...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7894189/ https://www.ncbi.nlm.nih.gov/pubmed/32876368 http://dx.doi.org/10.1002/cbic.202000406 |
_version_ | 1783653196562956288 |
---|---|
author | Hatton, Natasha E. Baumann, Christoph G. Fascione, Martin A. |
author_facet | Hatton, Natasha E. Baumann, Christoph G. Fascione, Martin A. |
author_sort | Hatton, Natasha E. |
collection | PubMed |
description | During their lifetime almost half of women will experience a symptomatic urinary tract infection (UTI) with a further half experiencing a relapse within six months. Currently UTIs are treated with antibiotics, but increasing antibiotic resistance rates highlight the need for new treatments. Uropathogenic Escherichia coli (UPEC) is responsible for the majority of symptomatic UTI cases and thus has become a key pathological target. Adhesion of type one pilus subunit FimH at the surface of UPEC strains to mannose‐saturated oligosaccharides located on the urothelium is critical to pathogenesis. Since the identification of FimH as a therapeutic target in the late 1980s, a substantial body of research has been generated focusing on the development of FimH‐targeting mannose‐based anti‐adhesion therapies. In this review we will discuss the design of different classes of these mannose‐based compounds and their utility and potential as UPEC therapeutics. |
format | Online Article Text |
id | pubmed-7894189 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | John Wiley and Sons Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-78941892021-03-02 Developments in Mannose‐Based Treatments for Uropathogenic Escherichia coli‐Induced Urinary Tract Infections Hatton, Natasha E. Baumann, Christoph G. Fascione, Martin A. Chembiochem Reviews During their lifetime almost half of women will experience a symptomatic urinary tract infection (UTI) with a further half experiencing a relapse within six months. Currently UTIs are treated with antibiotics, but increasing antibiotic resistance rates highlight the need for new treatments. Uropathogenic Escherichia coli (UPEC) is responsible for the majority of symptomatic UTI cases and thus has become a key pathological target. Adhesion of type one pilus subunit FimH at the surface of UPEC strains to mannose‐saturated oligosaccharides located on the urothelium is critical to pathogenesis. Since the identification of FimH as a therapeutic target in the late 1980s, a substantial body of research has been generated focusing on the development of FimH‐targeting mannose‐based anti‐adhesion therapies. In this review we will discuss the design of different classes of these mannose‐based compounds and their utility and potential as UPEC therapeutics. John Wiley and Sons Inc. 2020-11-02 2021-02-15 /pmc/articles/PMC7894189/ /pubmed/32876368 http://dx.doi.org/10.1002/cbic.202000406 Text en © 2020 The Authors. Published by Wiley-VCH GmbH This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Reviews Hatton, Natasha E. Baumann, Christoph G. Fascione, Martin A. Developments in Mannose‐Based Treatments for Uropathogenic Escherichia coli‐Induced Urinary Tract Infections |
title | Developments in Mannose‐Based Treatments for Uropathogenic Escherichia coli‐Induced Urinary Tract Infections |
title_full | Developments in Mannose‐Based Treatments for Uropathogenic Escherichia coli‐Induced Urinary Tract Infections |
title_fullStr | Developments in Mannose‐Based Treatments for Uropathogenic Escherichia coli‐Induced Urinary Tract Infections |
title_full_unstemmed | Developments in Mannose‐Based Treatments for Uropathogenic Escherichia coli‐Induced Urinary Tract Infections |
title_short | Developments in Mannose‐Based Treatments for Uropathogenic Escherichia coli‐Induced Urinary Tract Infections |
title_sort | developments in mannose‐based treatments for uropathogenic escherichia coli‐induced urinary tract infections |
topic | Reviews |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7894189/ https://www.ncbi.nlm.nih.gov/pubmed/32876368 http://dx.doi.org/10.1002/cbic.202000406 |
work_keys_str_mv | AT hattonnatashae developmentsinmannosebasedtreatmentsforuropathogenicescherichiacoliinducedurinarytractinfections AT baumannchristophg developmentsinmannosebasedtreatmentsforuropathogenicescherichiacoliinducedurinarytractinfections AT fascionemartina developmentsinmannosebasedtreatmentsforuropathogenicescherichiacoliinducedurinarytractinfections |